alpha-aminopyridine has been researched along with valproic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu Ali, H; Abuhijleh, AL; Akkawi, M; Darawsheh, M; Hussein, Y; Jaber, S; Maloul, S; Rappocciolo, E | 1 |
| Fu, R; Jing, Q; Li, Y; Liu, Z; Mi, F; Wang, Y; Xiang, C | 1 |
2 other study(ies) available for alpha-aminopyridine and valproic acid
| Article | Year |
|---|---|
New mixed ligand zinc(II) complexes based on the antiepileptic drug sodium valproate and bioactive nitrogen-donor ligands. Synthesis, structure and biological properties.
Topics: Aminopyridines; Anti-Bacterial Agents; Anticonvulsants; Antimalarials; Bacteria; Crystallography, X-Ray; Dose-Response Relationship, Drug; Hemeproteins; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organometallic Compounds; Phenanthrolines; Picolines; Quinolines; Structure-Activity Relationship; Valproic Acid; Zinc | 2014 |
The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF‑κB pathway in multiple myeloma cells.
Topics: Acetylation; Aminopyridines; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Histones; Humans; Multiple Myeloma; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Signal Transduction; Time Factors; Valproic Acid | 2019 |